Cohen, Joshua P.; Bridges, John F.P. - In: Applied Health Economics and Health Policy 7 (2009) 4, pp. 219-224
With the inclusion of $US1.1 billion earmarked for comparative effectiveness research (CER) in the recently enacted stimulus package, the US government indicated it will play an important role in informing prescribing and reimbursement decisions. However, this sizable investment does beg four...